Table 2.
N | g | 95% CI | Z | Q-Value | I 2 (%) | |
---|---|---|---|---|---|---|
Main comparison with all eligible RCTs | ||||||
Any risk of bias score included | 28 | 0.34** | 0.20, 0.49 | 4.63 | 52.83** | 49 |
High risk of bias (>1)a | 26 | 0.34** | 0.19, 0.49 | 4.43 | 51.12** | 51 |
Lowest risk of bias (0)b | 19 | 0.40** | 0.22, 0.58 | 4.40 | 41.49** | 59 |
CBTp vs TAU | ||||||
Any risk of bias score included | 22 | 0.35** | 0.18, 0.52 | 4.00 | 45.94** | 54 |
High risk of bias (>1)a | 20 | 0.34** | 0.17, 0.52 | 3.77 | 44.24** | 58 |
Lowest risk of bias (0)b | 14 | 0.41** | 0.19, 0.63 | 3.65 | 36.90** | 65 |
CBTp vs active intervention | ||||||
Any risk of bias score included | 8 | 0.34** | 0.15, 0.53 | 3.58 | 7.03 | 0 |
High risk of bias (>1)a | 8 | 0.34** | 0.15, 0.53 | 3.58 | 7.03 | 0 |
Lowest risk of bias (0)b | 5 | 0.42** | 0.20, 0.64 | 3.70 | 4.15 | 4 |
CBTp with hallucinations as primary outcomec | ||||||
Any risk of bias score included | 23 | 0.40** | 0.24, 0.56 | 4.90 | 40.42* | 46 |
High risk of bias (>1)a | 21 | 0.40** | 0.23, 0.57 | 4.66 | 38.84** | 49 |
Lowest risk of bias (0)b | 14 | 0.51** | 0.32, 0.70 | 5.22 | 25.67* | 49 |
CBTp with individualized case formulationd | ||||||
Any risk of bias score included | 21 | 0.41** | 0.25, 0.57 | 5.03 | 39.86* | 50 |
High risk of bias (>1)a | 20 | 0.42** | 0.26, 0.59 | 5.02 | 39.44* | 52 |
Lowest risk of bias (0)b | 15 | 0.45** | 0.25, 0.65 | 4.47 | 39.98** | 62 |
CBTp with individualized CF + primary outcomec,d | ||||||
Any risk of bias score included | 16 | 0.51** | 0.34, 0.68 | 5.99 | 23.15* | 35 |
High risk of bias (>1)a | 15 | 0.53** | 0.36, 0.70 | 6.01 | 22.24 | 37 |
Lowest risk of bias (0)b | 11 | 0.59** | 0.39, 0.80 | 5.73 | 18.64* | 46 |
Blinded RCTs onlye | ||||||
All eligible CBTp RCTs | 24 | 0.36** | 0.20, 0.51 | 4.48 | 49.10** | 53 |
Case formulation only | 19 | 0.43** | 0.26, 0.61 | 4.95 | 39.17** | 54 |
Case formulation + primary outcomec,d | 14 | 0.55** | 0.37, 0.73 | 5.99 | 21.36 | 39 |
Additional analyses | ||||||
Group CBTp | 4 | 0.11 | −0.18, 0.41 | 0.76 | 3.15 | 5 |
Hallucinations as secondary outcome | 5 | 0.05 | −0.15, 0.24 | 0.46 | 3.87 | 0 |
Virtual-reality CBTp | 2 | 0.56** | 0.22, 0.89 | 3.27 | 0.75 | 0 |
Self-help CBTp | 3 | 0.47 | −0.42, 1.37 | 1.03 | 9.26** | 78 |
After removal of 2 outliers | ||||||
Any risk of bias score included | 26 | 0.27** | 0.15, 0.40 | 4.37 | 34.35 | 27 |
High risk of bias (>1)a | 24 | 0.27** | 0.14, 0.39 | 4.16 | 32.52 | 29 |
Lowest risk of bias (0)b | 16 | 0.31** | 0.16, 0.46 | 4.05 | 24.21 | 39 |
Case formulation only | 19 | 0.32** | 0.19, 0.45 | 4.91 | 23.01 | 22 |
Case formulation + primary outcomec,d | 14 | 0.41** | 0.29, 0.54 | 6.56 | 9.64 | 0 |
Case formulation, primary outcome + RoBa–c | 9 | 0.44** | 0.31, 0.58 | 6.46 | 6.11 | 0 |
Excluding RCTs with high ratio nonschizophrenia spectrum | ||||||
Any risk of bias score included | 26 | 0.32** | 0.17, 0.47 | 4.23 | 49.46** | 50 |
Lowest risk of bias (0)b | 16 | 0.38** | 0.19, 0.57 | 3.92 | 38.78** | 61 |
Case formulation + primary outcomec,d | 16 | 0.47** | 0.30, 0.64 | 5.28 | 24.99 | 40 |
Case formulation, primary outcome + RoBa–c | 10 | 0.58** | 0.37, 0.79 | 5.35 | 17.58* | 49 |
Note: All comparisons were using random model. Risk of bias scores refer to assessment using adapted version of the Cochrane Risk of Bias tool (0–4). CBTp, cognitive behavioral therapy for psychosis; CF, case formulation; CI, confidence interval; g, Hedges’s g; n/a, not applicable; RCT, randomized controlled trial; RoB, risk of bias; TAU, treatment-as-usual.
Sensitivity analysis exclusions were as follows:
aRisk of bias score greater than 1 excluded: McLeod et al (2007); Peters et al (2010).
bRisk of bias score greater than 0 excluded: Cather et al (2005); Durham et al (2003); Gottlieb et al (2017); Krakvik et al (2013); Leff et al (2013); McLeod et al (2007). Peters et al (2010); Trouwer et al (2004); Wykes et al (2005).
cHallucinations as primary outcome only: Birchwood et al (2014); Garety et al (2008); Haddock et al (2009); Tarrier et al (2014); Trouwer et al (2004).
dCase formulation only: Freeman et al (2015); Gottlieb et al (2017); Hazell et al (2017); McLeod et al (2007); Penn et al (2009); Wykes et al (2005).
eNonblinded RCTs excluded: Krakvik et al (2013); McLeod et al (2007); Peters et al (2010).
*P < .05. **P < .01.